chrisvoncsefalvay/vaers-outcomes huggingface dataset:
have the flu even though I had a flu shot in October; Covid; Initial information received on 14-Dec-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves patient of unknown age and gender who have experienced the flu even though had a flu shot in october and covid after receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a unknown dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number, Strength, formulation, Expiry date was not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient experienced the flu even though had a flu shot in october (influenza) and covid (covid-19) (unknown latency) following the administration of INFLUENZA VACCINE.  No lab data was reported.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for both the events.  At time of reporting, the outcome was Unknown for both the events.
15.5 hours post-injection, woke up with low-grade fever and headache. 21.5 hours post-injection, sent home from school with 101 fever and severe headache. 26 hours post-injection, 102 fever, repetitive vomiting, lethargic. 38 hours post-injection, all symptoms completely resolved. The entire adverse event lasted less than 24 hours, leading us to believe this was a vaccine reaction and not an illness. Patient has a twin sister who received the same vaccination at the same time from the same lot, but exhibited only an insignificant and brief low-grade fever. Patient's previous COVID-19 immunizations were without adverse effects, BUT were Pfizer rather than Moderna.
I felt sunburnt on my back starting about 24 hours after the first and second doses. However, about once a day for about 15 minutes and at different times of day, the sunburnt sensation on my back comes back every day since the second dose.
exp inc HR & queasy feeling about 1-2 days p/vax happened occassionally throughout the day lasted about 2 wks; stated had similar signs & sx p/receiving 1st vax but states did not atribute it to the vax;
36 hours after vaccination, a raised red itchy rash developed on the back of my neck about the size of my palm.  12 hours later, the itchiness started to subside.  the raised bumps took about 4-5 days to completely heal and go away.
Onset of rash on trunk; gradually spreading to full body (including face); red, raised, whelpy with complaint of itching, generalized.
Case number PHEH2012US009583 is an initial spontaneous report received from a health care professional on 04 May 2012 with a follow-up received on 05 Jun 2012: This report refers to an 11-years-old male patient whose age, medical history, past drugs, current conditions and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: A10135) intramuscularly on 20 Mar 2012. On the same date, he experienced localized swelling and redness in arms as abnormal reaction at vaccination site (out of normal parameters). The outcome of the event was reported as complete recovery on 21 Mar 2012 and the causality was not provided. Follow-up received from a health care professional on 05 Jun 2012: Updated date of vaccination, event description, event onset date and recovery date.
About 6 hours after I received the flu shot I was watching TV. In the short space of a few seconds, a grey-colored "curtain" appeared and blocked the vision in precisely the upper half of my right eye. The bottom-half vision of the right eye remained clear, and all of the left eye vision remained clear. The grey curtain blocking my vision was confined to the upper half of the right eye only. The curtain remained there for about 3-5 minutes (my best estimate of the time), then fairly quickly disappeared. The vision in the right eye returned to normal and is still normal today, 18 days later. I did not seek medical attention. I had no other medical issues occurring in the weeks before that vision episode. It was puzzling to me until I remembered that six hours earlier I had received the high dose "senior" flu shot. Whether that flu shot caused it or not, I of course cannot tell, but the timing (6 hours after the shot) seemed suspicious, so I am reporting it to you. As I'm sure you'll understand, I am reluctant to get my personal information recorded in multiple databases, so I have omitted the non-required name/address/etc. But if you need any follow-up information, you may contact me. Thank you for all the good work you do in helping make the medical care safe and effective.
10 people received a dose from an expired vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (10 people received a dose from an expired vaccine) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021C21A) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (10 people received a dose from an expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (10 people received a dose from an expired vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment and concomitant medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 10-Jun-2021: Updated patient informations
Right wrist-2 hrs post vaccination faint red rash in 2 inch area. No itching. Area is not raised. Treated with one cap Benadryl per health officer order. Area was gone the following day. Family physician contacted per pt and did not feel it was related.
Information has been received from a medical assistant concerning a 16 week old male patient with no pertinent medical history, drug reactions or allergies who on 20-SEP-2010 was vaccinated orally with a first dose of ROTATEQ (Lot# 668264/0854Z) (Expiration date 07-APR-2012). Second dose of ROTATEQ (Lot# 668336/0518Z) (Expiration date 23-APR-2012) was given on 01-NOV-2010 and concomitantly received on the same date a dose of PENTACEL (Lot# C3748AB) and a dose of PREVNAR 13 (Lot# 914506). The medical assistant reported that on 01-NOV-2010, the patient began to have bloody stools. On 02-NOV-2010, the patient had also fever and was seen by the physician. The patient's fecal occult blood test was positive. The patient was sent to the Emergency Room to rule-out intussusception and intussusception was ruled out. The patient was not admitted to the hospital. On 03-NOV-2010, the patient was seen by the physician. The patient had mucus and blood in his stools. The patient was referred to a Gastroenterologist to rule out milk allergy (results not provided). The patient did not have any other symptoms besides mucus and blood in his stools. At the time of the report, the patient had not recovered. Upon internal review blood in stools was considered to be an other important medical event. Additional information has been requested.
Patient was vaccinated by EMT. Provider was not present for time of vaccination. Immediately following vaccination, patient complained of sharp, left sided arm pain. No other symptoms were reported by the patient. Patient reported that vaccinator had administered the dose too high on the arm and was concerned with long-term affects. Patient was examined by provider and found that injection site was highly-placed in on upper arm. Patient was able had intact FROM in both arms and shoulders.  Patient was advised to follow up with PCP  if nerve like pain persisted for more than 5 days and to follow up sooner with PCP if she developed difficulty moving her arm, shoulder or developed concerning symptoms.
INTENSE PAIN in muscles, in head, in skin,  and even in the bones! This was not just the flu-ish symptoms that one gets with flu (which I had a few years ago) or with flu vaccines (which I have had every year for many years), but it was INTENSE PAIN in the joints, on skin, in an intense headache that rivaled a migraine! I am not pain-sensitive and I was crying with the pain.  My fever was at 99.9.  On the 1-10 scale with 10 being a gallstone (which I've had and that hurt) this was up to 8 or 9.    My hands and feet also were hurting a lot (perhaps related to the psoriatic arthritis that is in remission but is an underlying condition).    The symptoms went away in about 24 hours.  Just FYI, I had the MODERNA vaccine, (second shot was March 9, 2021) and I had mild 24-hour reactions to that, flu-like symptoms but nothing like this.
administrated a 2nd dose 24 days after 1st; This case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too short in a 8-month-old male patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent 2021-2022 season) (batch number 9339n, expiry date 30th June 2022) for prophylaxis.   Co-suspect products included flu seasonal qiv quebec pre-filled syringe device (Flulaval Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   Concomitant products included INFLUENZA VIRUS VACCINE INACTIVATED (FLULAVAL QUADRIVALENT).   On 17th January 2022, the patient received the 2nd dose of FluLaval Quadrivalent 2021-2022 season and Flulaval Tetra Pre-Filled Syringe Device. On an unknown date, unknown after receiving FluLaval Quadrivalent 2021-2022 season and Flulaval Tetra Pre-Filled Syringe Device, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The patient was administrated a second dose of FluLaval QIV, 24 days after the first dose of the vaccine, which led to drug dose administration interval too short. No further events were reported.  Agreed to be contacted for follow-up.
Received second dose of GARDASIL. Approximately 16 hours later developed dizziness and fooling fainted and nausea. Fever weakness continued for several hours, controlled with TYLENOL.
Cognitive impairment - Difficulty organizing thoughts, expressing thoughts, word retrieval, completing tasks, way finding and focus.  Increased blood pressure  to 160-174/80s- 90s.  Evaluated by PCP with addition of Lisinopril 10 mg to manage hypertension.  Which has since returned to normal range. New medication started 11/16/21.  Referred to neurologist.  First visit with neurologist 12/7/21.  Mental status exam indicating delayed thought process, mild cognitive impairment.  MRI of the brain indicated small microvascular changes consistent with age.  No significant findings.  Symptoms seemed to increase through mid-December and have gradually improved since then.  Second evaluation with neurologist was 1/11/22.  At that time there was indication of improved spontaneity of speech, affect and ability to engage in and follow conversation.  Presently, cognition is close to 90% of baseline.
Racing heartbeat, sharp muscle pain at injection site within 10 minutes of vaccine. Significant fatigue, malaise, and body aches onset within 18 hours after injection and continued for the next three days. Continued intermittent muscle pain and stiffness of the injected extremity.
Initial and follow up information has been received from a physician and a health care worker concerning a 54 year old male with high cholesterol, who in approximately the year 2000 was vaccinated with pneumococcal 23v polysaccharide vaccine with reportedly, no adverse reaction.  On 23-OCT-2005, the patient was vaccinated, subcutaneously in the right arm, with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine on (Lot#650453/0791P).  Concomitant therapy included atorvastatin calcium (LIPITOR).  The physician reported that the next day (24-OCT-2005), the patient was not able to move the arm.  The patient was to be seen in the physician's office on 24-MAY-2006.  The patient sought unspecified medical attention.  At the time of the report, the patient had not recovered.  The physician reported that this patient is the second of two patients.  Additional information has been requested.
Chest pain upper left quadrant; Ringing in ears; Muscle weakness; Cold sweats; Insomnia; Headache; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old male patient received the second dose of BNT162b2 (COMIRNATY; Lot Number: FA7485) via an unspecified route of administration in the left arm on 13Aug2021 at 14:15 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. The patient previously took BNT162b2 (COMIRNATY; Lot Number: EW0612) via an unspecified route of administration in the left arm on 21Jul2021 at 14:15 as a single dose for COVID-19 immunisation. On 13Aug2021 at 16:45, the patient experienced chest pain upper left quadrant, ringing in ears, muscle weakness, cold sweats, insomnia, headache and fatigue. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chest pain upper left quadrant, ringing in ears, muscle weakness, cold sweats, insomnia, headache and fatigue was not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Several years ago, my doctor prescribed Clobetasol Propionate Cream when I had an itchy rash on one spot on my arm.  That took care of it and it didn't occur again.  However, since the October 2021 dose of Moderna, I have had very itchy, hives-like  red spots occur at multiple times  on various parts of my arms, one spot on my lower left leg and one spot on my right hip.  I've used the Clobetasol Cream on them.  It takes a few days for them to go away, but as soon as those spots go away,  more reappear in other areas on my arms.  That's what prompted me to report these occurrences to you.  I have not yet reported this to my PCP.   I see him in June 2022 and will report it then unless it worsens prior to then.
presenting to the emergency department from primary care clinic where he was noted to be hypotensive in have some new onset renal failure
pt felt right away, came back mid december arm still hurt, pt advised to take ibuprofen regularly for 2 weeks.  pt arm still sore as of today 1/12/22. informed pt to contact md
Received 2 doses of Pfizer covid vaccine. Patient unsure of date of first dose. Received 2nd dose 3/14/2021. Subsequently tested positive for covid infection on 7/26/2021.
Date of shot: Day 1 12:00  pm shot  given 5:00 pm pain at location shot was given 10:00 pm Both arms hurting 11:00 pm Upper Body aches, headache,  Day 2  12:00 am  - 5:00 am upper body aches, headache, hot/cold sweats, electric shock type feeling on my sides, teeth and jaw pain 5:00 am - 4:00 pm body aches, hot/cold sweats, loss of appetite 5:00 pm -10:00 pm body aches, head ache, loss of appetite 10:00 pm -11:59 pm slept Day 3 12:00 am - 5:00 am slept 5:00 am  11:59 pm reduced body aches 10:00 pm 2 lumps in neck / swollen lymph nodes  Day 4 swollen lymph nodes, low grade fever 99.9 on and off body aches and head aches Day 5 same as day 4 fever gone
Narrative:  Patient contacted telephone triage nurse today requesting to speak with PCP clinic. States he had a COVID BOOSTER SHOT 2 days ago, "I think I'm having some issues and I want to talk to my doctor." Patient states he felt okay the day he received the injection he felt fine, "But I woke up the next day and I'm so tired." States he has had fatigue and some very mild blurred vision ever since. No worse today than he was yesterday, "just wanted to make sure I'm not having some sort of reaction." Patient is otherwise asymptomatic. Still able to perform ADL's without difficulty. Some mild discomfort at injection site, R deltoid, "the site looks great, no redness or anything, healing well."
Patient reports receiving the 1st vaccination of a 2 part series of SHINGRIX on 3/28/18 at 11.00 am. Patient states that at 6:00 pm she started experiencing the following typical Adverse Events: Redness, Soreness and Swelling. Patient states that what concerned her were the following Adverse Events: Chills that were uncontrollable (3/28/18 night) and a knot, swelling and pain in her left arm that lasted for 5 days (3/28/18-4/2/18). Patient also states that she was very fatigued for "a few days" after the vaccination. Patient states that she called the Pharmacy on 3/29/18 and the pharmacist recommended she take TYLENOL 500mg twice a day which helped her pain. On 3/31/18 patient came in to the pharmacy to be assessed by the pharmacist. By Monday 4/2/18, patient states that she was back to normal with no redness, swelling or pain.
My son was born at 33 weeks and 1 day, via an unnecessary c-section. He remained in the NICU for 29 Days. He had blood sugar issues from day 1, and although he was immunocompromised, he was given his first vaccine, while in the NICU, less than 3 weeks after he was born. When he came home, although he was on medications (diazoxide to treat low blood sugars), the doctor continued to give him vaccines.   After the vaccination on 7/8/13, the next day, he became ill, was vomiting, eyes glassy, lethargic and weak. We called the doctor to inform him of what was going on, and he told us to head to the ER. While my  husband and I were driving, my son's head became droopy and his body became very relaxed. He was not acting like his normal self. When we got into the ER, we explained what happened, they assessed our son, and informed us that he had a "viral infection". As most health professionals, they explained it away as "something that was going around", although he had been completely well up until he received the vaccination.
Rash appeared on trunk then on extremities and face - morbilliform rash - appears to be like Rubella, no itching.  Appeared suddenly.
Mom states that received shots (Tdap/Menacta) on Tuesday, 9/7 @ facility, was noted to have diarrhea, fever, confusion, disorientation that afternoon. Mom states wasn't better on Wednesday, 9/8 - states he had fever, & severe weakness. on Thursday, 9/9 brought him in to facility to see MD b/c had fever, achiness. Was given a steroid to "boost immunity". Monday, 9/13 went to school; upon getting home told mom was having bad body aches and was very pale. Tuesday, 9/14 called from school b/c was nasueated and vomiting. Today not at all better: still w/ weakness, diarrhea, and fever never more than 100. 11 year 8 month old male presents with c/o Fatigue on and off- was better with the steroids. c/o Arthralgias Reported having body aches- leg pains/ sometimes his foot hurts, and sometimes his back hurts. c/o Headache for 2-3 days frontal, intermittent, mild. c/o Nasal congestion for 2 weeks stuffy in am and at night, moderate- last 6 days with thick yellow nasal discharge present. c/o Fever 101 - axillary at 100 - added a degree- on and off since immunizations last week. c/o Feeding difficulty drinking OK but not eating solids well. Denies : Cough.  Ear pain.  Sore throat.  Sick contacts.  Chest pain.  Shortness of breath.  Chest congestion.
Approx. 1 hour post injection, pt. came back with red, firm, warm knot approx. 2 1/2 in X 2 1/2 in.  Denies any other symptoms @ this time.  No tx @ this time.
This spontaneous report as received from a nurse refers to unspecified number of patients of unknown demography. No concurrent condition, medical history or allergy/drug reactions were reported. The nurse reported that on an unspecified date, unspecified number of patients were vaccinated with improperly stored GARDASIL injection (lot # K007828, expiry date: 02-MAR-2017) (dose, strength and route were not reported). No concomitant medications were reported. No adverse effects were reported. The outcome of the event was unknown. There were no product quality complaints (PQC) involved. No further information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
About 8/26/2003 developed blister at site of smallpox vaccine (received vaccine 3/6/03). Blister was fluid filled, drained and now scab at site.
This case was reported by a lawyer and described the occurrence of autoimmune disorder in a subject of unspecified age and gender who was vaccinated with LYMERIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. The following information was received via a legal complaint: The subject received LYMERIX (GlaxoSmithKline) given on 08 June 1999 and 14 July 1999. On 13 July 2000 the subject received the 3rd dose of LYMERIX (unknown). On 23 September 2010, ten years after the third vaccination with LYMERIX and based upon unspecified testing, the subject was potentially diagnosed with demyelinating disease. Based upon testing on 15 October 2010, the subject was diagnosed with white matter changes of the brain. On or after 15 October 2010, the patient was diagnosed with "post Lyme vaccination autoimmune syndrome". The patient was reported to have sustained "serious personal injuries and related losses" including "post-Lyme vaccination syndrome and/or treatment resistant Lyme arthritis", requirement for healthcare, medical and related expenses, mental anguish, physical pain and suffering, diminished capacity for enjoyment of life, diminished quality of life, diminished ability to work, and other losses and damages. This case was assessed as medically serious by GSK. At the time of reporting the outcome of the events was unspecified.
ospitalization: 10/25/22 - 10/31/22.  Presentation to the ED: WORSENING SOB. COVID + date: 10/25/22. Treatment: ceftriaxone, azithromycin, steroids and bronchodilator nebulization.  Discharge to:
Pt called clinic c/o of erythema, itching, small lump at injection site. Erythema was 40mm, lump was miniscule, approx 2mm. pt patient description over the phone today. She c/o not feeling well, being very sleepy & tired for 2 days post vaccination. 7 days post vaccine despite POLYSPORIN & povidone iodine application the rash/itchy is still present otherwise feels normal. Has appt. with PMD Thurs. 8/4/11. Advised CORTIZONE topical or BENADRYL topical to r/o allergy to vaccine component.
This spontaneous report was received from a physician via company representatives, referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 30-OCT-2014, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB (Lot No. J007946; expiration date 24-MAR-2016), "TF 5mcg/0.5mL Te" (route of administration and anatomical location were not reported). On an unspecified dates, the RECOMBIVAX HB had one temperature excursion: 48 hours  and the lowest recorded temperature was 1 F (1Celsius). No adverse effects reported. The vaccine status was reported as "in excursion". The vaccine storage criteria and the storage type of excursion were reported as "Refrigerator(R)". No product quality complaint was involved.
Bumpy rash starting on face and spreading to face.  Bumpy rash on legs only at 2 month vaccines given 9-20-2011.